Movement Alert｜WuXi Biologics Rises 3.47% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence

Market Focus

Jul 02

On July 2, WuXi Biologics rose 3.47% in regular trading, trading at 35.84 HKD/share, with turnover of 531 million HKD.

On the news front, the company has maintained an aggressive buyback pace. On June 30, it spent approximately 99.83 million HKD to repurchase 2.89 million shares. Since May 26, cumulative repurchases have exceeded 37.1 million shares totaling approximately 1.172 billion HKD, signaling management confidence in the company's intrinsic value. Additionally, three factories at the company's Wuxi production base passed Brazil's ANVISA GMP certification with zero findings, further validating its global commercial manufacturing capabilities.

Within the Life Sciences Tools and Services sector, multiple stocks posted gains. Among individual stocks, GenScript Bio up 4.66%, WuXi XDC up 3.33%, Insilico up 2.12%, XtalPi up 1.96%, demonstrating notable sector resonance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1156592347"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156592347\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156592347?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156592347","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi Biologics Rises 3.47% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence","media":"Market Focus","content":"<p><p>On July 2, WuXi Biologics rose 3.47% in regular trading, trading at 35.84 HKD/share, with turnover of 531 million HKD.</p><p>On the news front, the company has maintained an aggressive buyback pace. On June 30, it spent approximately 99.83 million HKD to repurchase 2.89 million shares. Since May 26, cumulative repurchases have exceeded 37.1 million shares totaling approximately 1.172 billion HKD, signaling management confidence in the company's intrinsic value. Additionally, three factories at the company's Wuxi production base passed Brazil's ANVISA GMP certification with zero findings, further validating its global commercial manufacturing capabilities.</p><p>Within the Life Sciences Tools and Services sector, multiple stocks posted gains. Among individual stocks, GenScript Bio up 4.66%, WuXi XDC up 3.33%, Insilico up 2.12%, XtalPi up 1.96%, demonstrating notable sector resonance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi Biologics Rises 3.47% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi Biologics Rises 3.47% in Regular Trading, Sustained High-Frequency Buybacks and Brazil GMP Certification Boost Confidence\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-02 10:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 2, WuXi Biologics rose 3.47% in regular trading, trading at 35.84 HKD/share, with turnover of 531 million HKD.</p><p>On the news front, the company has maintained an aggressive buyback pace. On June 30, it spent approximately 99.83 million HKD to repurchase 2.89 million shares. Since May 26, cumulative repurchases have exceeded 37.1 million shares totaling approximately 1.172 billion HKD, signaling management confidence in the company's intrinsic value. Additionally, three factories at the company's Wuxi production base passed Brazil's ANVISA GMP certification with zero findings, further validating its global commercial manufacturing capabilities.</p><p>Within the Life Sciences Tools and Services sector, multiple stocks posted gains. Among individual stocks, GenScript Bio up 4.66%, WuXi XDC up 3.33%, Insilico up 2.12%, XtalPi up 1.96%, demonstrating notable sector resonance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1156592347","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156592347","pubTimestamp":1782958242,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 2, WuXi Biologics rose 3.47% in regular trading, trading at 35.84 HKD/share, with turnover of 531 million HKD.On the news front, the company has maintained an aggressive buyback pace. On June...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"动向提示|药明生物常规交易涨3.47%持续高频回购及巴西GMP认证提振信心","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"On July 2, WuXi Biologics rose 3.47% in regular trading, trading at 35.84 HKD/share, with turnover of 531 million HKD.On the news front, the company has maintained an aggressive buyback pace. On June 30, it spent approximately 99.83 million HKD to repurchase 2.89 million shares. Since May 26, cumulative repurchases have exceeded 37.1 million shares totaling approximately 1.172 billion HKD, signaling management confidence in the company's intrinsic value. Additionally, three factories at the company's Wuxi production base passed Brazil's ANVISA GMP certification with zero findings, further validating its global commercial manufacturing capabilities.Within the Life Sciences Tools and Services sector, multiple stocks posted gains. Among individual stocks, GenScript Bio up 4.66%, WuXi XDC up 3.33%, Insilico up 2.12%, XtalPi up 1.96%, demonstrating notable sector resonance.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}